Postgrad Med J

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beyenburg, S
Right arrow Articles by Reuber, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beyenburg, S
Right arrow Articles by Reuber, M
Postgraduate Medical Journal 2004;80:581-587
© 2004 Fellowship of Postgraduate Medicine


REVIEW

New drugs for the treatment of epilepsy: a practical approach

S Beyenburg 1, J Bauer 2, M Reuber 3

1 Department of Neurology, Centre Hospitalier de Luxembourg, Luxembourg
2 Department of Epileptology, University of Bonn, Germany
3 Department of Neurology, Sheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital, Sheffield, UK

Correspondence to:
Correspondence to:
Dr S Beyenburg
Department of Neurology, Centre Hospitalier de Luxembourg, 4, rue Barblé, L-1210 Luxembourg; beyenburg.stefan{at}chl.lu

The availability of new antiepileptic drugs has broadened the spectrum of medical treatment options in epilepsy. The new agents, together with established drugs, offer substantial choice for doctors treating patients with focal or generalised epilepsy. The newer antiepileptic drugs are not necessarily more effective but usually better tolerated than the traditional agents, mainly because of favourable pharmacokinetic profiles and fewer interactions. Because treatment options have increased, drug therapy can now be tailored to the requirements of individual patients. Nevertheless, significant safety and efficacy issues continue to exist and there is a need for the development of even better agents. This review describes the clinical use of the new antiepileptic drugs, but focuses in particular on monotherapy, the treatment of generalised seizures, teratogenicity, and the cognitive side effect profile of the newer compounds.


Abbreviations: GABA, gamma aminobutyric acid; JME, juvenile myoclonic epilepsy; NICE, National Institute for Clinical Excellence

Keywords: antiepileptic drugs; epilepsy; generalised seizures




This article has been cited by other articles:


Home page
NeurologyHome page
M. L. Zupanc
Antiepileptic drugs and hormonal contraceptives in adolescent women with epilepsy
Neurology, March 28, 2006; 66(66_suppl_3): S37 - S45.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 The Fellowship of Postgraduate Medicine